Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Next-Generation Sequencing Informatics Market Set To Climb From $11.96 Billion In 2026 To $22.14 Billion By 2030
The next-generation sequencing informatics market has shown substantial growth in recent years. This market is expected to expand from $10.23 billion in 2025 to $11.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.9%. Historically, this expansion has been driven by factors such as a surge in demand for precision diagnostics, the advancement of high-throughput sequencers, an increase in genomic research initiatives, heightened awareness of personalized medicine, and the broader development of bioinformatics capabilities.
The next-generation sequencing informatics market is poised for significant expansion over the coming years, with projections indicating a rise to $22.14 billion by 2030, at a compound annual growth rate (CAGR) of 16.6%. This anticipated growth can be linked to several factors, including ongoing technological improvements in NGS informatics software, the increasing adoption of cloud-based genomic platforms, a rise in collaborations between biotechnology and pharmaceutical firms, the growing incidence of genetic disorders, and the incorporation of AI and machine learning into genomics analysis. Key developments expected during this period involve AI-driven genomic data analysis, the emergence of cloud-based sequencing platforms, wider application of personalized medicine, enhanced automation in NGS workflows, and the integration of Internet of Things (IoT) in genomic research.
Get A Free Sample Report With In-Depth Market Insights:
Next-Generation Sequencing Informatics Market Growth Factors: What’s Supporting Expansion?
The expanding integration of personalized medicine is anticipated to drive the advancement of the next-generation sequencing informatics market in the future. Personalized medicine is defined as a healthcare method that customizes treatment and prevention plans to suit an individual’s distinct genetic profile, lifestyle choices, and environmental factors. The rising acceptance of personalized medicine largely stems from progress in genomics, which allows for the accurate detection of genetic differences and the development of customized therapies for patients. Next-generation sequencing informatics bolsters personalized medicine through its capacity for thorough genomic data analysis, positioning it as an optimal tool for bespoke treatment approaches and precise healthcare delivery. It diminishes diagnostic ambiguity by pinpointing genetic variations and forecasting disease susceptibility, thereby refining clinical choices and patient results. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that the U.S. Food and Drug Administration (FDA) sanctioned 26 novel personalized medicines in 2023, representing a notable rise from the 12 approved during 2022. Consequently, the growing embrace of personalized medicine is stimulating the expansion of the next-generation sequencing informatics market.
Next-Generation Sequencing Informatics Market Segment Landscape: Which Areas Lead Development?
The next-generation sequencing informatics market covered in this report is segmented –
1) By Offering: Software, Platforms, Services
2) By Product And Services: Storage And Computing Tools, Commercial Data Analysis, Data Interpretation And Reporting Tools, Informatics Services
3) By Deployment Mode: Cloud, On-Premise, Hybrid
4) By Application: Research And Development, Clinical Diagnostics, Drug Discovery, Agrigenomics
5) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinical Laboratories, Agricultural Biotechnology Companies
Subsegments:
1) By Software: Data Analysis Software, Data Management And Storage Tools, Workflow Management Software, Sequence Alignment Tools, Variant Analysis Software, Clinical Interpretation Software
2) By Platforms: On-Premises Platforms, Cloud-Based Platforms, Hybrid Platforms
3) By Services: Data Analysis Services, Consulting And Implementation Services, Data Management And Storage Services, Technical Support And Maintenance Services, Training And Education Services
Next-Generation Sequencing Informatics Market Industry Trends: What’s Reshaping Demand?
Leading firms within the next-generation sequencing informatics (NGS) market are prioritizing the creation of sophisticated solutions, including cloud-based platforms, aiming to boost scalability, strengthen data security, and optimize genomic workflows. These platforms represent digital frameworks that allow researchers and medical professionals to store, process, and analyze substantial amounts of sequencing data, whether housed on distant servers or integrated into local institutional settings. As an illustration, in March 2023, Illumina Inc., a US biotechnology firm, introduced Connected Insights, a novel cloud-based software specifically developed for the tertiary analysis of clinical next-generation sequencing (NGS) data. This software facilitates genomic data interpretation and reporting, incorporates more than 45 external knowledge sources, and decreases the time required to generate clinical reports. Connected Insights automates the process of variant interpretation and report creation, thereby minimizing manual work and establishing consistent workflows across various assay categories, including comprehensive genomic profiling (CGP) panels, whole-exome sequencing (WES), and transcriptomic data.
Next-Generation Sequencing Informatics Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the next-generation sequencing informatics market are DNAnexus Inc., SOPHiA GENETICS SA, DNASTAR Inc., Geneious Biomatters Ltd., CosmosID Inc., QIAGEN N.V., Seven Bridges Genomics Inc., PierianDx Inc., Fabric Genomics Inc., Golden Helix Inc., Partek Incorporated, Real Time Genomics Inc., Sentieon Inc., Roche NimbleGen Inc., Agilent Alissa Interpret, WuXi NextCODE Genomics, DNAVision SA, Genoox Ltd., Congenica Ltd., PierianDx Holdings, Bionano Genomics Inc.
View The Full Next-Generation Sequencing Informatics Market Report:
Next-Generation Sequencing Informatics Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the next-generation sequencing informatics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing informatics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
